Bluegrass Beacon: Frankfort should butt out of private-sector’s purview

Both projects at the heart of this legislative edition of Liberty Boosters and Busters offer reminders of the costly, if unintended, consequences of government involvement in undertakings better left to the private sector. However, there’s at least an attempt to limit one project’s ability to undercut private-sector competition with a publicly subsidized product while costly…

No taxpayer-financed bailout for sick hospital!

Disastrous, costly policy proposals often center around government picking winners and losers rather than the time-honored and historically proven approach of allowing the marketplace to determine which enterprises succeed and fail. After its parent company announced plans to close downtown Louisville’s Jewish Hospital, which has hemorrhaged financially for years, the University of Louisville stepped in…

Should the state loan U of L millions of taxpayer dollars to purchase fiscally failing Jewish Hospital?

Bluegrass Institute president and CEO Jim Waters spoke recently at the Louisville Forum in opposition to a proposed $50 million “partially forgivable” taxpayer-backed loan from the commonwealth to assist the University of Louisville in its purchase of Jewish Hospital. (Since this presentation, U of L has reduced the amount of its loan request to $35…

Prescription-drug policy: Remove obstacles keeping alternatives from reaching the market

We’ve focused in the first two posts of this three-part series addressing prescription-drug policy (here and here) on proposals in the United States Senate which offer solutions in search of problems, harm competition and allow brand-name drug companies to continue keep life-saving generics off the market for longer periods of time – all  with costly…

Prescription-drug policy: Don’t throw the bed out with bedpan

According to IQVIA, a health-care data firm, generic prescription drugs saved Kentucky $5.7 billion in 2017, $3.2 billion of which were savings reaped by the commonwealth’s Medicare and Medicaid programs. However, legislation (S. 64) being considered by the U.S. Senate would delay Kentucky patients access the more-affordable generic and biosimilar drugs being developed today. In…

Prescription-drug policy: Don’t give the FDA power over standards for biosimilar medicine

While Kentucky Senator and Majority Leader Mitch McConnell’s proposal to raise the legal age of purchasing tobacco has received a large share of attention regarding the suite of healthcare proposals currently being considered in the U.S. Senate, other issues affecting cost and access to health care – including for prescription drugs – must be carefully…

Bluegrass Beacon: More government for all!

Editor’s note: The Bluegrass Beacon is a weekly syndicated statewide newspaper column posted on the Bluegrass Institute’s website after being released to and published by newspapers statewide. Progressives never count themselves satisfied with expanding government a single time in one lone area. Grotesque growth by government in one area like health insurance never stops do-gooders…